Edema News and Research

RSS

Edema means swelling caused by fluid in your body's tissues. It usually occurs in the feet, ankles and legs, but it can involve your entire body.

Fatty acid-derived bioactive molecule helps improve heart function after heart attack in mice

Heart attacks provoke an acute immune response. Leukocytes rush to the heart muscle to remove dead cells and begin building scar tissue. This is followed by a second immune response, the resolving phase that allows healing.

7 Sep 2017

Sodium channels play important role in keeping tiny lung capillaries from leaking, worsening pneumonia

Sodium channels in the cells that line the tiny capillaries in our lungs play an important role in keeping those capillaries from leaking and potentially worsening conditions like pneumonia, scientists report.

6 Sep 2017

$Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL$

Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL

Novartis announced today that the US Food and Drug Administration has approved Kymriah (tisagenlecleucel) suspension for intravenous infusion, formerly CTL019, the first chimeric antigen receptor T cell (CAR-T) therapy, for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse.

30 Aug 2017

Super fleas with oversized penises all set to invade Britain !

According to scientists, super fleas with penises that are two and half times their size, are all set to invade the British homes this soggy summer and bring with them a host of diseases. They warn that the damp weather this August following a hot spring has led to the successful breeding of these bugs.

13 Aug 2017

An exercise pill for heart failure patients

According to latest research, scientists at the Ottawa University, Canada have come up with a pill that can mimic the effects of regular exercise. This could be significantly beneficial to heart failure patients. The study was published in the journal Nature.

10 Aug 2017

$New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod$

New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod

The U.S. Food and Drug Administration (FDA) in a statement yesterday reported its approval for a new drug, Idhifa (enasidenib) for the treatment of acute myeloid leukemia (AML) in adults that has either relapsed or is refractory to standard chemotherapy.

2 Aug 2017

Researchers find neuroprotective effects of trigeminal nerve stimulation in severe TBI

Researchers at the Feinstein Institute for Medical Research and the department of neurosurgery at the Hofstra Northwell School of Medicine, announced today that they have published a paper with research findings that could have implications for the treatment of many neurological conditions, including severe traumatic brain injury (TBI).

28 Jul 2017

Quantel Medical wins FDA approval for innovative Easyret photocoagulator

Quantel Medical today announced that it has received approval from the U.S. Food and Drug Administration on July 25, 2017 for the innovative new Easyret fully integrated 577nm yellow photocoagulator, which is used to treat certain forms of macular edema and peripheral retinal pathologies.

27 Jul 2017

Drowning can occur even while on dry land

Drowning is one of the biggest problems in the United States, and considering the number of people who will head to bodies of water to cool off this summer, we are entering the riskiest months.

21 Jul 2017

Experimental drug increases progression-free survival in pancreatic cancer patients, clinical trial shows

By adding an experimental drug to a standard chemotherapy regimen, a subset of patients with metastatic pancreatic cancer had a significantly longer period before the cancer progressed as compared with those who received the standard treatment, according to a Phase 2 clinical trial led by an investigator at Fred Hutchinson Cancer Research Center.

1 Jun 2017

Women with obstructive sleep apnea may be at increased risk for pregnancy complications

Women with obstructive sleep apnea (OSA) appear to be at greater risk for serious pregnancy complications, longer hospital stays and even admission to the ICU than mothers without the condition, according to a new study of more than 1.5 million pregnancies presented at the ATS 2017 International Conference.

22 May 2017

Two widely used drugs show effectiveness in treating patients with CRVO-associated macular edema

Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the treatment of central retinal vein occlusion, according to a clinical trial funded by the National Eye Institute, part of the National Institutes of Health.

10 May 2017

UVA research finding sheds light on cause of deadly heart condition

Kidney research at the University of Virginia School of Medicine has unexpectedly led to a discovery about the formation of the heart, including the identification of a gene responsible for a deadly cardiac condition.

9 May 2017

Takeda announces accelerated approval from FDA for new lung cancer treatment

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that ALUNBRIG (brigatinib) has received Accelerated Approval from the U.S. Food and Drug Administration for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer who have progressed on or are intolerant to crizotinib.

28 Apr 2017

FDA approves new drug and chemotherapy combination for treatment of adult patients with AML

The U.S. Food and Drug Administration today approved Rydapt (midostaurin) for the treatment of adult patients with newly diagnosed acute myeloid leukemia who have a specific genetic mutation called FLT3, in combination with chemotherapy.

28 Apr 2017

New plant therapy developed at WPI cures patients with drug-resistant malaria

When the standard malaria medications failed to help 18 critically ill patients, the attending physician in a Congo clinic acted under the "compassionate use" doctrine and prescribed a not-yet-approved malaria therapy made only from the dried leaves of the Artemisia annua plant.

25 Apr 2017

New article finds rising trend in hospitalization for hypertensive emergency with reduction in mortality

A new article published in the American Journal of Hypertension finds a rising trend in hospitalization for hypertensive emergency with reduction in hospital mortality during the last decade. The presence of acute cardiorespiratory failure, chest pain, stroke, acute chest pain, and aortic dissection were most predictive of higher hospital mortality among other complications.

21 Apr 2017

WHO marching toward extraordinary progress against neglected tropical diseases, report reveals

Since 2007, the World Health Organization (WHO) has been reporting outstanding success in dealing with neglected tropical diseases (NTDs) with 1 billion people estimated to have received treatments in 2015.

19 Apr 2017

Scientists discover novel therapeutic target for retinal neovascularization

A team led by Massachusetts Eye and Ear researchers has identified a novel therapeutic target for retinal neovascularization, or abnormal blood vessel growth in the retina, a hallmark of advanced diabetic eye disease (proliferative diabetic retinopathy).

11 Apr 2017

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Amgen and UCB today announced results from the fourth year of a Phase 2 study showing the efficacy and safety of a second course of treatment with EVENITY™* (romosozumab), an investigational agent for postmenopausal women with osteoporosis.

3 Apr 2017